{"id":41631,"date":"2025-01-16T18:33:36","date_gmt":"2025-01-16T18:33:36","guid":{"rendered":"https:\/\/avendrapharma.com\/2025\/01\/16\/macushield-the-triple-protection-for-the-macula-that-our-eyes-need-today\/"},"modified":"2026-05-30T15:33:33","modified_gmt":"2026-05-30T15:33:33","slug":"macushield-the-triple-protection-for-the-macula-that-our-eyes-need-today","status":"publish","type":"post","link":"https:\/\/avendrapharma.com\/en\/2025\/01\/16\/macushield-the-triple-protection-for-the-macula-that-our-eyes-need-today\/","title":{"rendered":"MACUSHIELD: The triple protection for the macula that our eyes need today"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\"Picture\n\t\t\t\t<\/div>\n\t\t\t\n\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t

\n\t\t\t\t\t\t\tAssoc. Prof. Desislava KOLEVA, MD\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t

Associate Professor Desislava Koleva, MD, is a renowned vitreoretinal specialist with extensive experience in the surgery of severe eye diseases \u2013 Retinal detachment, macular holes, vitreous haemorrhages, diabetic retinopathy, eye injuries, and other posterior segment eye diseases that are difficult to diagnose and treat.<\/p>\n

She has numerous specialisations and courses in Bulgaria and abroad. She obtained a specialisation in
Ophthalmology in 2006. In 2010 \u2013 a Diploma from the European Board of Ophthalmology (EBO). In 2012 \u2013 a Diploma for a Doctor of Ophthalmology educational and scientific degree after defending her doctoral dissertation on the topic: \u201cClinical evaluation of diabetic macular edema using spectral optical coherence tomography\u201d. And in 2018 \u2013 a Habilitation Diploma \u2013 Associate Professor of Ophthalmology. <\/p>\n

Associate Professor Koleva consults and performs surgical treatment for cataracts, including complicated cataracts, as well as combined eye surgeries. She works in several eye medical facilities. She is the manager of \u201cAssoc. Prof. Desislava Koleva -\u201cSt. Luke\u201d Ltd., Plovdiv. She performs consulting and surgical activities as an ophthalmologist at MC \u201cVereya\u201d Ltd., Stara Zagora, in the ophthalmology department at MBAL \"Trimontium\u201d Ltd., Plovdiv, in the Clinic of Eye Diseases at UMBAL \u201cSt. George\u201d EAD. She is a lecturer at Medical University \u2013 Plovdiv. <\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

As an eye doctor, I see hundreds of patients every year who come with the same fear in their eyes: \u201cMy vision isgetting worse… Is this macular degeneration?\u201d<\/em><\/p>

The truth is, macular degeneration doesn’t appear suddenly. It starts quietly, slowly, almost imperceptibly.First, we lose contrast. Then, in the centre of vision, letters start to \u201cblur\u201d. Faces become harder to recognise. And most importantly \u2014 this process can be slowed down. But only if we protect the macular pigment \u2014 the eye’s natural shield.<\/p>

– Assoc. Prof. Desislava KOLEVA, MD<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
<\/path><\/svg><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

What actually happens to the macula? The truth that few patients know: <\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The macular pigment is composed of three carotenoids: lutein, zeaxanthin, and meso-zeaxanthin. These molecules act as a \u201cyellow filter\u201d that stops blue light and as an antioxidant shield that protects the finest part of the retina. After the age of 25, the macular pigment begins to thin \u2014 by an average of 1% each year. This was established in a study with 800 volunteers (1. Nolan et al., 2006). <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"MacuShield\"<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Who is most at risk?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

According to the study by Nolan et al., 2006, the following factors reduce macular pigment density: age, smoking, female gender, and family history of macular degeneration.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Why are the three carotenoids so important?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Macular pigment is a complex three-component structure, where each carotenoid has a precisely defined place \u2014 like perfectly arranged tiles on a shield that protects the most valuable part of vision \u2013 the macula.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/path><\/path><\/svg><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Lutein<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

the outer protective layer \u2013 Lutein accumulates predominantly in the more peripheral parts of the macularpigment. It acts as an \u201couter filter\u201d that first intercepts and blocks blue light. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/path><\/path><\/svg><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Zeaxanthin<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

the middle layer, the zone of fine vision \u2013 Zeaxanthin concentrates in the intermediate zone of the macula, the area that supports detailed and contrast vision. It is optimised for absorbing light in the range where photoreceptors are most vulnerable. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/path><\/path><\/svg><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Meso-zeaxanthin<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

the heart of the system, the central \u201ccrown\u201d \u2013 Meso-zeaxanthin is found in the very centre of the macula \u2014 the fovea. This small area is responsible for the sharpest detailed vision, for recognising faces, reading text, and close-up work. It is precisely there that the eye is most vulnerable. And it is precisely there that the carotenoid with the strongest antioxidant activity \u2014 meso-zeaxanthin \u2014 is found. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

How do the three work together?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Their combination is not a mechanical sum of three substances \u2014 it is a biological synergy, proven in both preclinical and clinical models:<\/p>

1. They cover different ranges of the light spectrum <\/span><\/strong><\/p>

Each carotenoid absorbs blue light in a slightly different range. Therefore, the triple combination protects against a wider spectre of harmful light. <\/p>

2. They create a uniform \u201cphotoprotective filter\u201d<\/strong><\/p>

Because they are spatially separated into three con- centric layers, they form a complete three-dimensional shield that has no \u201cweak spots\u201d. If even one of them is missing, there is a hole in the shield \u2013 especially in the centre. <\/p>

3. They work as an antioxidant team<\/strong><\/p>

Meso-zeaxanthin is the most powerful antioxidant, but it is further activated in the presence of lutein and zeaxanthin. The three mutually regenerate and reinforce each other, leading to: a stronger neutralising effect against free radicals, faster stabilisation of macular cells, and a greater increase in macular pigment. <\/p>

4. They cover all three anatomical zones of the macula<\/strong><\/p>

This is the key: without all three together, the natural structure of the macular pigment, as nature created it, can never be achieved. <\/span><\/p>

The three together form a complete protective shield, not partial protection.<\/span><\/p>

That is why a product like MACUSHIELD<\/strong>, which uniquely contains all three carotenoids, has the strongest effect on: increasing macular pigment, improving contrast sensitivity, slowing the progression of macular degeneration, and protecting central vision.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

And the most important question is: how do we restore this protective pigment?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

For years, patients took so-called \u201ceye vitamins\u201d based on lutein, vitamin A, and zinc. Today, science shows that these formulas are no longer sufficient, and sometimes even risky. According to Hoang & Tolentino, 2016, ref.3, outdated formulas with vitamin A and zinc should be replaced with the triple combination: meso-zeaxanthin, lutein, and zeaxanthin, such as MACUSHIELD.<\/strong> <\/p>

The large clinical study CREST AMD<\/b><\/p>

The CREST AMD study (2. Akuffo, Beatty, Peto, Nolan et al.,2017) shows that the triple combination significantlyincreases macular pigment density, improves contrast sensitivity, reduces glare sensitivity (photophobia), and slows the progression of the disease. Even more impressively, within two years, not a single patient in the group receiving the triple combination progressed to a more severe stage of the disease. The authors’ conclusion is unequivocal: <\/p>

\u201cRegular intake of a triple combination of carotenoids such as MACUSHIELD<\/strong> in patients with non-advanced age-related macular degeneration leads to significant increases in macular pigment density, improvement in contrast sensitivity, and other indicators of visual function.\u201d<\/p>

This means one thing: MACUSHIELD<\/strong> not only nourishes the macula but also offers a real chance to preserve vision longer and slow the progression of the disease.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Conclusion<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Macular degeneration is a slow erosion, and science is unequivocal. MACUSHIELD<\/strong> \u2013 the only triple combination of lutein, zeaxanthin, and meso-zeaxanthin is the most effective approach to protecting the macula. <\/span><\/p>

MACUSHIELD<\/strong> is the standard for modern prevention of macular degeneration. The earlier we start, the more vision we preserve. Macular degeneration is a challenge, but not a sentence. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
BUY NOW<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

As an eye doctor, I see hundreds of patients every year who come with the same fear in their eyes: \u201cMy vision isgetting worse… Is this macular degeneration?\u201d The truth is, macular degeneration doesn’t appear suddenly. It starts quietly, slowly, almost imperceptibly.First, we lose contrast. Then, in the centre of vision, letters start to \u201cblur\u201d.…<\/p>\n","protected":false},"author":1,"featured_media":41632,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[185],"class_list":["post-41631","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-eye-health","tag-cover-post"],"_links":{"self":[{"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/posts\/41631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/comments?post=41631"}],"version-history":[{"count":1,"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/posts\/41631\/revisions"}],"predecessor-version":[{"id":41633,"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/posts\/41631\/revisions\/41633"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/media\/41632"}],"wp:attachment":[{"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/media?parent=41631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/categories?post=41631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avendrapharma.com\/en\/wp-json\/wp\/v2\/tags?post=41631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}